CANGO INC/KY - ADR (CANG)

US1375861036 - ADR

1.55  +0.07 (+4.73%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CANG. CANG was compared to 126 industry peers in the Specialty Retail industry. CANG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CANG is not valued too expensively and it also shows a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CANG has reported negative net income.
The reported net income has been mixed in the past 5 years: CANG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CANG reported negative operating cash flow in multiple years.

1.2 Ratios

CANG's Return On Assets of -9.84% is on the low side compared to the rest of the industry. CANG is outperformed by 72.22% of its industry peers.
With a Return On Equity value of -12.46%, CANG perfoms like the industry average, outperforming 42.06% of the companies in the same industry.
Industry RankSector Rank
ROA -9.84%
ROE -12.46%
ROIC N/A
ROA(3y)3.94%
ROA(5y)4.09%
ROE(3y)4.8%
ROE(5y)5.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CANG has a Gross Margin of 8.55%. This is amonst the worse of the industry: CANG underperforms 93.65% of its industry peers.
CANG's Gross Margin has declined in the last couple of years.
CANG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-46.74%
GM growth 5Y-29.95%

More info and screens

6

2. Health

2.1 Basic Checks

CANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CANG has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CANG has been reduced compared to 5 years ago.
CANG has a better debt/assets ratio than last year.

2.2 Solvency

CANG has an Altman-Z score of 1.87. This is not the best score and indicates that CANG is in the grey zone with still only limited risk for bankruptcy at the moment.
CANG's Altman-Z score of 1.87 is on the low side compared to the rest of the industry. CANG is outperformed by 63.49% of its industry peers.
CANG has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
CANG has a Debt to Equity ratio of 0.02. This is in the better half of the industry: CANG outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 1.87
ROIC/WACCN/A
WACC7.46%

2.3 Liquidity

CANG has a Current Ratio of 4.13. This indicates that CANG is financially healthy and has no problem in meeting its short term obligations.
CANG has a better Current ratio (4.13) than 96.83% of its industry peers.
CANG has a Quick Ratio of 4.13. This indicates that CANG is financially healthy and has no problem in meeting its short term obligations.
CANG has a better Quick ratio (4.13) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.13
Quick Ratio 4.13

More info and screens

5

3. Growth

3.1 Past

CANG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.63%.
Looking at the last year, CANG shows a very negative growth in Revenue. The Revenue has decreased by -19.07% in the last year.
The Revenue has been growing by 13.48% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q55.85%
Revenue 1Y (TTM)-19.07%
Revenue growth 3Y11.21%
Revenue growth 5Y13.48%
Revenue growth Q2Q-15.07%

3.2 Future

The Earnings Per Share is expected to grow by 61.25% on average over the next years. This is a very strong growth
CANG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.06% yearly.
EPS Next Y30.2%
EPS Next 2Y61.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.72%
Revenue Next 2Y72.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANG. In the last year negative earnings were reported.
CANG is valuated cheaply with a Price/Forward Earnings ratio of 3.67.
Based on the Price/Forward Earnings ratio, CANG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CANG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.88.
Industry RankSector Rank
PE N/A
Fwd PE 3.67

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CANG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CANG's earnings are expected to grow with 61.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CANG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANGO INC/KY - ADR

NYSE:CANG (5/3/2024, 7:04:00 PM)

1.55

+0.07 (+4.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap161.77M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.67
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.84%
ROE -12.46%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 8.55%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.13
Quick Ratio 4.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-16.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y30.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.07%
Revenue growth 3Y11.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y